Jorge da Silva
Founder bei MOONLAKE IMMUNOTHERAPEUTICS
Vermögen: 160 Mio $ am 31.03.2024
Profil
Jorge Santos da Silva is the founder of Moonlake Immunotherapeutics AG, founded in 2021, where he holds the title of Chief Executive Officer.
He is also the founder of MoonLake Immunotherapeutics, founded in 2022, where he currently holds the title of Chief Executive Officer & Director.
Dr. da Silva's current job is as a Professor at the University of Minho, where he is currently employed.
He previously worked as a Senior Partner at McKinsey & Co., Inc. Dr. da Silva's education history includes an undergraduate degree from the University of Glasgow and a doctorate degree from the University of Turin.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.03.2024 | 2 982 814 ( 4,98% ) | 150 Mio $ | 31.03.2024 | |
| 15.03.2024 | 196 316 ( 2,19% ) | 10 Mio $ | 31.03.2024 |
Aktive Positionen von Jorge da Silva
| Unternehmen | Position | Beginn |
|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Founder | 05.04.2022 |
| University of Minho | Corporate Officer/Principal | - |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The private company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Chief Executive Officer | 01.07.2021 |
Ehemalige bekannte Positionen von Jorge da Silva
| Unternehmen | Position | Ende |
|---|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.06.2021 |
Ausbildung von Jorge da Silva
| University of Glasgow | Undergraduate Degree |
| University of Turin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Health Technology |
| Private Unternehmen | 2 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The private company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
